Fred Hutch

CAR T-cell therapy is a game changer in the treatment of certain types of blood cancers, particularly when other treatments have not been successful or the cancer has relapsed. Dr. Emily Liang explains how this therapy modifies a patient’s own immune cells to better recognize and attack cancer cells. #bloodcancerawarenessmonth #immunotherapy

For the health conscious or worry prone, whole-body magnetic resonance imaging (MRI) sounds enticing. What better way to protect your body and ease your mind than to look deeply into your tissues and organs for irregularities? Facilities that offer whole-body MRI promise to screen for hundreds of medical conditions simultaneously. Some use language likening the procedure to a medical crystal ball, showing the future by revealing silent abnormalities that could erupt into life-altering illnesses. The reality is more complex. In most people, these costly scans detect benign spots, nodules, cysts or other findings that are likely to never cause a problem or need treatment. When it comes to cancer, radiologists at Fred Hutch Cancer Center and UW Medicine advise using targeted, evidence-based screening methods, like mammography and colonoscopy, instead. Read more: https://bit.ly/4lNsjyJ

Curious what a diet of a GI doctor and gut health researcher looks like? Here's everything Fred Hutch's Dr. Neel Dey ate over two weeks: https://bit.ly/3JW1ta5

After his lung cancer diagnosis, Vinh Bui & wife Tram Le chose to give back, funding cancer research that could change lives. Their endowed chair empowers David MacPherson to more quickly translate fundamental discoveries about cancer biology into targeted treatments for patients with small cell lung cancer. https://bit.ly/3JEscIn

Fred Hutch and the University of Washington are recruiting an assistant or associate professor on the clinician-scholar pathway for pulmonary critical care medicine. Join a world-class team advancing clinical care and research in lung disease, immunotherapy and transplantation. Learn more and apply: https://bit.ly/4fRtNq2

Join Fred Hutch Cancer Center and UW Medicine for the 16th Annual Hematology & Oncology Review Course, October 6–10 in Seattle. This accredited, in-person symposium offers a comprehensive update on the latest data, guidelines, and therapeutic advances in hematology and medical oncology — ideal for clinicians preparing for board certification or recertification. Register: https://bit.ly/4jPeM8C

The Cancer AI Alliance (CAIA) has been recognized in TIME's list of the 100 most influential people in #AI through Fred Hutch Vice President and Chief Data Officer Jeff Leek‬. Created in 2024, CAIA is a groundbreaking collaboration that harnesses the latest AI breakthroughs and unparalleled computing power to create an environment ripe for transformative discoveries. By bridging cancer centers, research disciplines and industries, CAIA is laying the groundwork to unlock AI's full potential in the pursuit of cancer research breakthroughs. Read more: https://bit.ly/4mChH6R #TIME100AI

Fred Hutch is pleased to be among the early grantees of the Fund for Science and Technology (FFST), a new Paul Allen estate-backed foundation that plans to fund at least $500 million over the next four years to support transformational science and technology. “This funding will support Fred Hutch research on the cells and tissues of the immune system to uncover new ways to treat cancer and autoimmune diseases," said Dr. Lawrence Fong, scientific director of Fred Hutch's Immunotherapy Integrated Research Center. "By combining cutting-edge technologies with Fred Hutch’s legacy of leadership in immunotherapy, we’re working to design more precise, more effective cell therapies to improve human health." Read more: https://bit.ly/4g2utJC

Fred Hutch is seeking a dedicated physician-scientist with a strong focus on T-cell Lymphoma and B-cell Diseases, and a passion for clinical and translational research in hematologic malignancies, especially lymphoma. Learn more and apply: https://lnkd.in/g8Cs6hs3